Results 131 to 140 of about 6,645 (195)
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.
BACKGROUND Prurigo nodularis (PN) is a neuroimmune skin disease characterized by the presence of chronic itch (≥6 weeks) and multiple white-pink papules, nodules and/or plaques.
F. Legat +22 more
semanticscholar +2 more sources
BACKGROUND Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns ...
Y. Valdman-Grinshpoun +4 more
semanticscholar +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2016
Characterized by the clinical presentation of individual to multiple symmetrically distributed, hyperkeratotic, and intensely itchy papules and nodules, prurigo nodularis (PN) is a rare disease that emerges in patients with chronic pruritus due to continuous scratching over a long period of time.
Athanasios, Tsianakas +2 more
openaire +2 more sources
Characterized by the clinical presentation of individual to multiple symmetrically distributed, hyperkeratotic, and intensely itchy papules and nodules, prurigo nodularis (PN) is a rare disease that emerges in patients with chronic pruritus due to continuous scratching over a long period of time.
Athanasios, Tsianakas +2 more
openaire +2 more sources
Prurigo Nodularis: New insights into pathogenesis and novel therapeutics.
British Journal of DermatologyPrurigo nodularis (PN) is an inflammatory skin condition characterized by intensely pruritic nodules on the skin. PN patients suffer from an intractable itch-scratch cycle leading to impaired sleep, psychosocial distress, and a significant disruption in ...
Viviane Liao +3 more
semanticscholar +1 more source
British Journal of Dermatology
BACKGROUND The biological therapy nemolizumab has been shown to improve the signs and symptoms of prurigo nodularis (PN) to a significantly greater extent than placebo over 16 weeks of treatment.
H. Yokozeki, H. Murota, T. Matsumura
semanticscholar +1 more source
BACKGROUND The biological therapy nemolizumab has been shown to improve the signs and symptoms of prurigo nodularis (PN) to a significantly greater extent than placebo over 16 weeks of treatment.
H. Yokozeki, H. Murota, T. Matsumura
semanticscholar +1 more source
Prurigo nodularis: disease burden, clinical features and approach to management.
British Journal of DermatologyPrurigo nodularis (PN) is a distinct, chronic inflammatory skin disease characterised by intensely pruritic, fibrotic nodular lesions. Despite continued progress in the field, lack of clarity regarding the definition of PN as a disease, clinical ...
S. Kwatra +5 more
semanticscholar +1 more source
Indian Journal of Dermatology, Venereology and Leprology
Background Interleukin (IL)-4, IL-13, IL-17, IL-22 and IL-3 are overexpressed in prurigo nodularis (PN). They mediate their action via the Janus Kinase (JAK) Signal transducer and activator of transcription (STAT) pathway. Objectives Our aim was to study
K. Sardana +4 more
semanticscholar +1 more source
Background Interleukin (IL)-4, IL-13, IL-17, IL-22 and IL-3 are overexpressed in prurigo nodularis (PN). They mediate their action via the Janus Kinase (JAK) Signal transducer and activator of transcription (STAT) pathway. Objectives Our aim was to study
K. Sardana +4 more
semanticscholar +1 more source
Increased risk of psychiatric disease in patients with prurigo nodularis.
British Journal of DermatologyPrurigo nodularis (PN) is a chronic skin disorder. Emerging, though limited, evidence suggests an association between PN and psychiatric comorbidities.
Salam Alfarsi +9 more
semanticscholar +1 more source
Improvement of Prurigo Nodularis With Erenumab.
JAMA dermatologyThis case report describes a patient in her 50s with prurigo nodularis and itch at the elbows, which spread to all extremities, the trunk, and genital area.
M. Pereira, M. Metz
semanticscholar +1 more source
International Journal of Dermatology
Prurigo nodularis/chronic nodular prurigo (PN/CNP) is a subtype of chronic prurigo characterized by pruritic nodules on the limbs and trunk. It predominantly affects older adults and women.
J. Armario-Hita +11 more
semanticscholar +1 more source
Prurigo nodularis/chronic nodular prurigo (PN/CNP) is a subtype of chronic prurigo characterized by pruritic nodules on the limbs and trunk. It predominantly affects older adults and women.
J. Armario-Hita +11 more
semanticscholar +1 more source

